Madrigal Pharmaceuticals, Inc.
Technical analysis of Madrigal Pharmaceuticals, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company that develops therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. Founded in 2016, Madrigal Pharmaceuticals is headquartered in West Conshohocken, Pennsylvania.
Description generated automatically from public sources; it may be inaccurate or out of date.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the MDGL analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Madrigal Pharmaceuticals, Inc.
How is Madrigal Pharmaceuticals, Inc. analysed technically?
Technical analysis of Madrigal Pharmaceuticals, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Madrigal Pharmaceuticals, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Madrigal Pharmaceuticals, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Madrigal Pharmaceuticals, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.